TELA Bio (TELA) Change in Acquisitions & Divestments (2020)
TELA Bio (TELA) posted Change in Acquisitions & Divestments of $5.3 million for Q2 2020, up 32.22% on a QoQ basis from $4.0 million in Q1 2020.
Powered by 
Analysis
TELA Bio (TELA) Change in Acquisitions & Divestments (2020) Analysis & Trends
TELA Bio has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $5.3 million in Q2 2020.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $5.3 million in Q2 2020; TTM through Dec 2020 was $9.3 million, a N/A change from a year earlier, with the FY2020 full-year figure at $9.3 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments was $5.3 million for Q2 2020 at TELA Bio, up from $4.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $5.3 million in Q2 2020, with the low at $4.0 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn |